TFX gains 2.9% after acquiring BIOTRONIK's vascular unit, boosting its cath lab presence and innovation pipeline.

Doctors at a Mumbai hospital have successfully treated a 66-year-old man suffering from advanced metastatic prostate cancer, ...

This case is unique because it documents a rare occurrence of a Type IV stent fracture following percutaneous coronary ...

Analysis highlights the widespread underuse of statins and cholesterol-lowering therapies among eligible adults in the United ...

In this high-yield, clinically focused session, Dr. Steven L. Cohn, one of the leading experts in perioperative medicine, ...

A substudy reports that optical coherence tomography resulted in less vessel failure after percutaneous coronary angioplasty ...

Teleflex Incorporated announced that it has completed the acquisition of substantially all of the Vascular Intervention ...

SNS Insider Unveils Strategic Insights into the U.S. Coronary Stent Market's Acceleration—Valued at USD 4.42 Billion in 2023—As the Nation Leads Global Adoption of Next-Gen Cardiovascular Technologies ...

Left main coronary artery (LMCA) disease can lead to what's known as a "widowmaker" heart attack, so-called because of the ...

Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced that it has completed ...

More than a quarter of people with a deadly form of heart disease may be missed following current tests, according to ...

Tens of thousands of people with the most aggressive type of heart disease could die as a result of insufficient diagnostic ...